Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 14514962 15322242 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
4.09 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.14 | 11473722 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.44 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.05 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.05 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.08 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.28 | 16712894 17306315 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.61 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.64 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.40 | 17967414 16873680 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.59 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.62 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.88 | 12948864 18497071 16675129 19861407 17289903 17018787 17261762 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.88 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.88 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.80 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.87 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.87 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.87 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.87 | 15276417 16507464 17306315 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.93 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
5.04 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
5.04 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.63 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.37 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.37 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
17.37 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.37 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.35 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.35 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 8697196 15668235 16354765 12621046 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.43 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.49 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.89 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.97 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.74 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.74 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.88 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
12.88 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.88 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.31 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.13 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.16 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.38 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.38 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.52 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.52 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.02 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.30 | 16221962 19772884 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.30 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.41 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.52 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.36 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.13 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 18606429 15340226 16354765 16959395 8697196 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.25 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.29 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.21 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.21 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.53 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.95 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.14 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
resveratrol |
5.44 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.44 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.92 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.69 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.69 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.80 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.80 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.80 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.95 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.95 | 15610895 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.72 | 16087638 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.50 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.50 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.50 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
15.10 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
15.10 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
15.10 | 19321006 19812893 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
15.10 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.10 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.28 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.28 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.32 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.53 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.53 | 17306315 17077188 15276417 19931552 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.53 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.56 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
4.07 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.58 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.64 | 11408345 16891317 17203775 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.64 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.86 | 19453300 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.61 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.61 | 16487513 19082730 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.62 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
OMIM:612703 |
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 7 |
marker/mechanism |
|
| |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.63 | 16490592 17164350 17049120 16267019 14749477 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.21 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.03 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
6.03 | 16525036 17015251 17125593 16456233 17188708 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.66 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.66 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.87 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.87 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
5.10 | 17322642 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.29 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.29 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
10.27 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
10.27 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.07 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.42 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.42 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.29 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
4.01 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.66 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.52 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.05 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.05 | 17306315 15276417 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
10.74 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.74 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.13 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.57 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.57 | 17718901 17636462 17675339 17804756 15767336 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.57 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.96 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.92 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.92 | 17520802 15827377 16317513 17058453 16314181 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
10.07 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
10.07 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
10.07 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.98 | 12854658 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.71 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.06 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.44 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.58 | 16452187 11723127 17306315 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
10.34 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
10.34 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.42 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.76 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.61 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |